Problem in COVID-19 trial..

  • 08 Apr 20

ISAC (International Society of Antimicrobial Chemotherapy) declared that there are serious problems in the study published in IJAA by Dr. Gautret titled "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".

Read More…

COVID-19 and CLINICAL RESEARCH Information area..

  • 03 Apr 20

You can find documents, guidelines, reports and other information in Clinical Research Association COVID-19 Information Area..

Read More…

Statement on COVID-19: Ethical Considerations from a Global Perspective...

  • 02 Apr 20

UNESCO prepared a paper on "Statement on COVID-19: Ethical Considerations from a Global Perspective".

Read More…

FDA initiated "Coronavirus Treatment Acceleration Program (CTAP)"...

  • 02 Apr 20

FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program (CTAP). It uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.

Read More…

Preserving Clinical Trial Integrity During the Coronavirus Pandemic...

  • 30 Mar 20

JAMA published an article on Preserving Clinical Trial Integrity During the Coronavirus Pandemic.

Read More…

FDA and EMA joined against COVID-19 in vaccine trials..

  • 28 Mar 20

On 18 March 2020 teleconference of global regulators convened jointly by the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) under the auspices of the International Coalition of Medicines Regulatory Authorities (ICMRA)

Read More…

FDA Guideline on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic..

  • 19 Mar 20

The guideline is directed to Industry, Investigators, and Institutional Review Boards.

Read More…

CORONAVIRUS clinical research...

  • 15 Mar 20

A lot of clinical research started against COVID-19. Some of them are new, some of them are old drug and vaccines.

Vaccines:

  1. Altimmune’s intranasal coronavirus vaccine
  2. INO-4800 by Inovio Pharmaceuticals and Beijing Advaccine Biotechnology
  3. NP-120 (Ifenprodil) by Algernon Pharmaceuticals
  4. APN01 by University of British Columbia and APEIRON Biologics
  5. mRNA-1273 vaccine by Moderna and Vaccine Research Center
  6. Avian Coronavirus Infectious Bronchitis Virus (IBV) vaccine by MIGAL Research Institute
  7. TNX-1800 by Tonix Pharmaceuticals
  8. Recombinant subunit vaccine by Clover Biopharmaceuticals
  9. Vaxart’s coronavirus vaccine
  10. Linear DNA Vaccine by Applied DNA Sciences and Takis Biotech
  11. Novavax’s MERS coronavirus vaccine
  12. Inovio Pharma’s INO-4700

Drugs against COVID-19 or complications:

  1. Remdesivir (GS-5734) by Gilead Sciences
  2. Actemra by Roche
  3. Biocryst Pharma’s Galidesivir
  4. Regeneron’s REGN3048-3051
  5. Brilacidin by Innovation Pharmaceuticals
  6. CytoDyn-leronlimab
  7. BXT-25 by BIOXYTRAN

    Read More…

Three Remdesevir and 1 vaccine trial against COVID-19..

  • 13 Mar 20

One study was initiated by Gilead in Spain and looks for IV Remdesevir in 2 age cohorts. The other study in USA compares Remdesevir with Placebo. The third study in Europe compares Remdesivir with an HIV drug combination (Ritonavir/Lopinavir) and HIV drug combination + IFN-Beta arms. The vaccine study is done in USA.

Read More…

UK MRC ensures that all clinical trials it funds are registered and results reported...

  • 07 Mar 20

The Medical Research Council has revealed details of how it monitors its grantees to ernsure that all clinical trials it funds are registered and report their results.
Please read the news from this link.

Read More…